A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Reza Rassool Named Business Wire’s Chief Technology Officer, Focused on Innovation and Client Experience
Elon Musk threatens to sue the ADL for lost X ad sales
New Jersey utilities float solar panels on reservoir, powering water treatment plant
Biden Ordered to Sell Gulf Of Mexico Oil Leases Next Month
Majority of Nurses Attribute Well-Being Struggles to Staffing Shortages
Snapchat+ gains 4 million paying subscribers in its first year
Foxconn: Apple supplier drops out of $20bn India factory plan
Ransomware Attack Hits Japan’s Biggest Port, Delaying Cargo